Literature DB >> 32833351

The Propagation, Quantification, and Storage of Vesicular Stomatitis Virus.

Alaa A Abdelmageed1, Maureen C Ferran1.   

Abstract

Vesicular stomatitis virus (VSV) is the prototypical member of the Rhabdoviridae family of negative-sense single-stranded RNA viruses. This virus has been used as a powerful model system for decades and is currently being used as a vaccine platform and an oncolytic agent. Here, we present methods to propagate, quantitate, and store VSV. We also review the proper safety protocol for the handling of VSV, which is classified as a Biosafety Level 2 pathogen by the United States Centers for Disease Control and Prevention.
© 2020 Wiley Periodicals LLC. Basic Protocol 1: Generation, purification, and storage of vesicular stomatitis virus stocks Basic Protocol 2: Quantification of vesicular stomatitis virus by plaque assay Support Protocol: Propagation of Vero cells. © 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  plaque assay; propagation; quantification; stock; storage; titration; vesicular stomatitis virus

Mesh：

Year:  2020        PMID： 32833351      PMCID： PMC7449588          DOI： 10.1002/cpmc.110

Source DB:  PubMed          Journal:  Curr Protoc Microbiol        ISSN： 1934-8525


  16 in total

1.  Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease.

Authors:  Marilyn Fernandez; Mercedes Porosnicu; Dubravka Markovic; Glen N Barber
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 2.  Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer.

Authors:  Eric Hastie; Valery Z Grdzelishvili
Journal:  J Gen Virol       Date:  2012-10-10       Impact factor: 3.891

Review 3.  Ebola vaccine R&D: Filling the knowledge gaps.

Authors:  Donata Medaglini; Ali M Harandi; Tom H M Ottenhoff; Claire-Anne Siegrist
Journal:  Sci Transl Med       Date:  2015-12-09       Impact factor: 17.956

4.  Evaluation of vesicular stomatitis virus mutant as an oncolytic agent against prostate cancer.

Authors:  Xin Zhao; Shengsong Huang; Huarong Luo; Xiaodong Wan; Yaping Gui; Junliang Li; Denglong Wu
Journal:  Int J Clin Exp Med       Date:  2014-05-15

5.  Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.

Authors:  Eric Hastie; Dahlia M Besmer; Nirav R Shah; Andrea M Murphy; Megan Moerdyk-Schauwecker; Carlos Molestina; Lopamudra Das Roy; Jennifer M Curry; Pinku Mukherjee; Valery Z Grdzelishvili
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

6.  Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones.

Authors:  S P Whelan; L A Ball; J N Barr; G T Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

7.  Zika Virus: Quantification, Propagation, Detection, and Storage.

Authors:  Darrell S Agbulos; Larissa Barelli; Bryan V Giordano; Fiona F Hunter
Journal:  Curr Protoc Microbiol       Date:  2016-11-18

8.  rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment.

Authors:  Thomas P Monath; Patricia E Fast; Kayvon Modjarrad; David K Clarke; Brian K Martin; Joan Fusco; Richard Nichols; D Gray Heppner; Jakub K Simon; Sheri Dubey; Sean P Troth; Jayanthi Wolf; Vidisha Singh; Beth-Ann Coller; James S Robertson
Journal:  Vaccine X       Date:  2019-01-29

Review 9.  Delivery and Biosafety of Oncolytic Virotherapy.

Authors:  Lizhi Li; Shixin Liu; Duoduo Han; Bin Tang; Jian Ma
Journal:  Front Oncol       Date:  2020-04-16       Impact factor: 6.244

Review 10.  Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses.

Authors:  Olga V Matveeva; Peter M Chumakov
Journal:  Rev Med Virol       Date:  2018-09-13       Impact factor: 6.989
View more
  5 in total

1.  Gene cloning, prokaryotic expression and antiviral activities of interferon-αω from Chinese Bama miniature pigs.

Authors:  Aziz Ullah Noor; Zhanyu Du; Huipeng Lu; Xiaohui Zhou; Xiaoming Liu; Jingjing Xiao; Xinyu Zhang; Huaichang Sun
Journal:  Vet Res Commun       Date:  2021-09-28       Impact factor: 2.459

2.  Gene Cloning, Tissue Expression Profiles and Antiviral Activities of Interferon-β from Two Chinese Miniature Pig Breeds.

Authors:  Aziz Ullah Noor; Zhanyu Du; Chengyi Song; Huipeng Lu; Xiaohui Zhou; Xiaoming Liu; Xinyu Zhang; Huaichang Sun
Journal:  Vet Sci       Date:  2022-04-15

Review 3.  Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?

Authors:  Yuguo Zhang; Bolni Marius Nagalo
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

4.  Recombinant Decoy Exhibits Broad Protection against Omicron and Resistance Potential to Future Variants.

Authors:  Haoneng Tang; Yong Ke; Lei Wang; Mingyuan Wu; Tao Sun; Jianwei Zhu
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-15

5.  Computational prediction of intracellular targets of wild-type or mutant vesicular stomatitis matrix protein.

Authors:  Matthew C Morris; Thomas M Russell; Cole A Lyman; Wesley K Wong; Gordon Broderick; Maureen C Ferran
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.